2 unknown. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Glomerulosclerosis, Focal Segmental: new trials by email Literature Review of Glomerulosclerosis, Focal Segmental trials Research Report on Glomerulosclerosis, Focal Segmental
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome Rituximab, Prednisone - Idiopathic Nephrotic Syndrome, Minimal Change Disease | Phase 3 | Unknown | Radboud University Medical Center | 40 | 2018-08-22 | 2018-08-27 |
| Valproic Acid for Idiopathic Nephrotic Syndrome Valproic Acid - Idiopathic Nephrotic Syndrome, Focal Segmental Glomerulosclerosis | Phase 2 / Phase 3 | Unknown | Universitair Ziekenhuis Brussel | 15 | 2016-10-01 | 2017-06-20 |
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Glomerulonephritis (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Nephritis (2) · Nephrosis (2) · Urogenital Diseases (2) · Urologic Diseases (2)
Prednisolone (1) · Prednisone (1) · Rituximab (1) · Valproic Acid (1)
Radboud University Medical Center (1) · Universitair Ziekenhuis Brussel (1)
Belgium (1) · Netherlands (1)
Jack F Wetzels, MD, PhD (1) · Jeroen K Deegens, MD,PhD (1) · Peter Janssens, MD (1)